Epilepsy is a neurological disorder caused by abnormal neuronal discharges in the brain, characterized by a complex pathogenesis, and it is particularly prevalent among children, with approximately one-third of children with epilepsy still cannot effectively control their seizures. Lacosamide is a third-generation novel sodium channel blockers for anti-epileptic seizures. It has the advantages of rapid absorption, high bioavailability, biological equivalence among different formulations, and minimal drug interactions. Currently, it is approved for monotherapy or combination therapy for focal seizures in children aged 4 and above. This article reviewed the anti-epileptic mechanism, pharmacokinetics, monotherapy and combination therapy feedback of lacosamide, aiming to provide a reference for the selection of treatment plans for childhood epilepsy.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |